# Climb Bio, Inc.: filings

CLYM · Nasdaq · CIK 1768446 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clym.md) · [Financials](/companies/clym/financials.md) · [Filings](/companies/clym/filings.md) · [Insiders](/companies/clym/insiders.md)

## Reports and events: 113 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 96, 8-K 64, 3 23, 10-Q 16, CORRESP 10, SC 13D/A 10, DEFA14A 8, D 7, SC 13G/A 7, S-8 6, UPLOAD 6, 10-K 5, SC 13G 5, SCHEDULE 13D/A 5, 144 4, ARS 4, DEF 14A 4, EFFECT 4, S-1/A 4, SCHEDULE 13G 4, S-3 3, 424B3 2, 424B5 2, DRS/A 2, DRSLTR 2, SC 13D 2, SCHEDULE 13G/A 2, 10-K/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, DEFM14A 1, DRS 1, FWP 1, PRE 14A 1, PREM14A 1, S-1 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 06:24 ET | [8-K](/filings/0001193125-26-430997.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-430997 |
| 2026-10-23 | 17:26 ET | [8-K](/filings/0001193125-26-430681.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-430681 |
| 2026-09-03 | 07:50 ET | [8-K](/filings/0001193125-26-381060.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-381060 |
| 2026-08-14 | 08:30 ET | [8-K](/filings/0001193125-26-350596.md) | 8.01 Other events | 0001193125-26-350596 |
| 2026-08-06 | 07:45 ET | [10-Q](/filings/0001193125-26-336774.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336774 |
| 2026-08-06 | 07:35 ET | [8-K](/filings/0001193125-26-336762.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336762 |
| 2026-07-07 | 16:41 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000189.md) | Ownership report, active investor, amended | 0001346824-26-000189 |
| 2026-07-01 | 16:15 ET | [8-K](/filings/0001193125-26-292567.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-292567 |
| 2026-06-12 | 16:36 ET | [8-K](/filings/0001193125-26-269567.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-269567 |
| 2026-06-11 | 07:12 ET | [8-K](/filings/0001193125-26-266688.md) | 8.01 Other events | 0001193125-26-266688 |
| 2026-06-08 | 16:07 ET | [8-K](/filings/0001193125-26-261716.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-261716 |
| 2026-06-05 | 07:12 ET | [8-K](/filings/0001193125-26-258372.md) | 8.01 Other events | 0001193125-26-258372 |
| 2026-05-07 | 07:30 ET | [10-Q](/filings/0001193125-26-210357.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210357 |
| 2026-05-07 | 07:05 ET | [8-K](/filings/0001193125-26-210295.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210295 |
| 2026-05-05 | 07:45 ET | [8-K](/filings/0001193125-26-205079.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-205079 |
| 2026-04-29 | 18:44 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000123.md) | Ownership report, active investor, amended | 0001346824-26-000123 |
| 2026-04-28 | 08:30 ET | [8-K](/filings/0001193125-26-183711.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-183711 |
| 2026-04-24 | 16:13 ET | [DEF 14A](/filings/0001193125-26-177271.md) | Proxy statement, period 2026-06-05 | 0001193125-26-177271 |
| 2026-04-03 | 16:05 ET | [8-K](/filings/0001193125-26-142114.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-142114 |
| 2026-03-05 | 07:20 ET | [10-K](/filings/0001193125-26-092546.md) | Annual report, period 2025-12-31 | 0001193125-26-092546 |
| 2026-03-05 | 07:10 ET | [8-K](/filings/0001193125-26-092520.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-092520 |
| 2026-01-08 | 07:07 ET | [8-K](/filings/0001193125-26-006994.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-006994 |
| 2025-12-31 | 16:12 ET | [8-K](/filings/0001193125-25-338318.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-338318 |
| 2025-12-15 | 19:56 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000074.md) | Ownership report, active investor, amended | 0001346824-25-000074 |
| 2025-12-11 | 08:16 ET | [8-K](/filings/0001193125-25-315108.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-315108 |
| 2025-11-06 | 07:21 ET | [10-Q](/filings/0001193125-25-268086.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268086 |
| 2025-11-06 | 07:15 ET | [8-K](/filings/0001193125-25-268075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268075 |
| 2025-10-17 | 07:11 ET | [8-K](/filings/0001193125-25-241951.md) | 8.01 Other events | 0001193125-25-241951 |
| 2025-10-16 | 17:48 ET | [SCHEDULE 13D/A](/filings/0001193125-25-241629.md) | Ownership report, active investor, amended | 0001193125-25-241629 |
| 2025-10-07 | 16:51 ET | [SCHEDULE 13D/A](/filings/0001193125-25-233582.md) | Ownership report, active investor, amended | 0001193125-25-233582 |
| 2025-10-01 | 17:23 ET | [8-K](/filings/0001193125-25-227025.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-227025 |
| 2025-09-29 | 07:48 ET | [8-K](/filings/0001193125-25-221756.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-221756 |
| 2025-08-12 | 07:15 ET | [10-Q](/filings/0000950170-25-106916.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106916 |
| 2025-08-12 | 07:10 ET | [8-K](/filings/0000950170-25-106913.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106913 |
| 2025-06-18 | 07:08 ET | [8-K](/filings/0001193125-25-142359.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-142359 |
| 2025-06-05 | 16:05 ET | [8-K](/filings/0001193125-25-135864.md) | 5.07 Shareholder vote results | 0001193125-25-135864 |
| 2025-05-23 | 16:26 ET | [8-K](/filings/0001193125-25-125866.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-125866 |
| 2025-05-14 | 07:10 ET | [10-Q](/filings/0000950170-25-070902.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070902 |
| 2025-05-14 | 07:05 ET | [8-K](/filings/0000950170-25-070901.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070901 |
| 2025-04-25 | 16:01 ET | [DEF 14A](/filings/0001193125-25-096697.md) | Proxy statement, period 2025-06-04 | 0001193125-25-096697 |
| 2025-04-01 | 07:14 ET | [8-K](/filings/0001193125-25-069668.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-069668 |
| 2025-03-25 | 16:46 ET | [8-K](/filings/0001193125-25-062629.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-062629 |
| 2025-03-25 | 16:01 ET | [10-K](/filings/0000950170-25-044350.md) | Annual report, period 2024-12-31 | 0000950170-25-044350 |
| 2025-01-10 | 08:08 ET | [8-K](/filings/0001193125-25-004129.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events | 0001193125-25-004129 |
| 2024-11-12 | 16:05 ET | [8-K](/filings/0000950170-24-125336.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-125336 |
| 2024-11-12 | 16:00 ET | [10-Q](/filings/0000950170-24-125294.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125294 |
| 2024-10-15 | 07:08 ET | [8-K](/filings/0001193125-24-237196.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-237196 |
| 2024-10-02 | 16:15 ET | [8-K](/filings/0001193125-24-231167.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-231167 |
| 2024-08-27 | 17:21 ET | [8-K](/filings/0001193125-24-207854.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-207854 |
| 2024-08-26 | 07:07 ET | [8-K](/filings/0001193125-24-206655.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-206655 |

Page 1 of 3. [Older](/companies/clym/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 08:52 ET. No prices; not investment advice.